TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by ...
- EMBARK for Clinical Trials (“EMBARK CT ”) being developed as a scalable model of psychedelic facilitation training to support future pivotal studies - - American Medical Association (“AMA”)’s new ...
TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by ...
MAUI -- Signature Travel Network is doubling down on support for new travel advisors with the relaunch of its Signature Embark training program. The program has two levels, with the more advanced ...
By working alongside Cybin to streamline the EMBARK Training Program, we aim to co-create a scalable program that will support a multi-site, global Phase 3 trial of CYB003, that ultimately contributes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback